Sirolimus-coated balloons were noninferior to paclitaxel-coated balloons in terms of safety and efficacy in treating patients with femoropopliteal artery disease, based on findings from the ...
New late-breaking science from TCT 2025 in San Francisco adds new evidence to discussions around the use of drug-eluting balloons (DEBs) – specifically the SELUTION SLR DEB – compared with routine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback